Selected research
Market Structure
Global Aminocaproic Acid Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Aminocaproic Acid Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Aminocaproic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Aminocaproic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Aminocaproic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Aminocaproic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Aminocaproic Acid Injection include Civica, Baiao Pharmaceutical, Changzhou Lanling Pharmaceutical, Chengdu Brilliant Pharmaceutical, Daiichi Sankyo, Guangdong Wonterfull ITD Pharmaceutical, Hunan Er-Kang Pharmaceutical, Pfizer and Jiangsu Yuexing Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Aminocaproic Acid Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Aminocaproic Acid Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Aminocaproic Acid Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Aminocaproic Acid Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Aminocaproic Acid Injection Segment by Company
Civica
Baiao Pharmaceutical
Changzhou Lanling Pharmaceutical
Chengdu Brilliant Pharmaceutical
Daiichi Sankyo
Guangdong Wonterfull ITD Pharmaceutical
Hunan Er-Kang Pharmaceutical
Pfizer
Jiangsu Yuexing Pharmaceutical
Southwest Pharmaceutical
Yangzhou Zhongbao Pharmaceutical
Aminocaproic Acid Injection Segment by Type
20ml
8ml
Other
Aminocaproic Acid Injection Segment by Application
Hospital
Clinic
Other
Aminocaproic Acid Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aminocaproic Acid Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aminocaproic Acid Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aminocaproic Acid Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Aminocaproic Acid Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aminocaproic Acid Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Aminocaproic Acid Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Aminocaproic Acid Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 20ml
- 8ml
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Civica
- Baiao Pharmaceutical
- Changzhou Lanling Pharmaceutical
- Chengdu Brilliant Pharmaceutical
- Daiichi Sankyo
- Guangdong Wonterfull ITD Pharmaceutical
- Hunan Er-Kang Pharmaceutical
- Pfizer
- Jiangsu Yuexing Pharmaceutical
- Southwest Pharmaceutical
- Yangzhou Zhongbao Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Aminocaproic Acid Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Aminocaproic Acid Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Aminocaproic Acid Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Aminocaproic Acid Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Aminocaproic Acid Injection Market Dynamics
- 2.1 Aminocaproic Acid Injection Industry Trends
- 2.2 Aminocaproic Acid Injection Industry Drivers
- 2.3 Aminocaproic Acid Injection Industry Opportunities and Challenges
- 2.4 Aminocaproic Acid Injection Industry Restraints
3 Aminocaproic Acid Injection Market by Manufacturers
- 3.1 Global Aminocaproic Acid Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Aminocaproic Acid Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Aminocaproic Acid Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Aminocaproic Acid Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Aminocaproic Acid Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Aminocaproic Acid Injection Manufacturers, Product Type & Application
- 3.7 Global Aminocaproic Acid Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Aminocaproic Acid Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Aminocaproic Acid Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Aminocaproic Acid Injection Tier 1, Tier 2, and Tier 3
4 Aminocaproic Acid Injection Market by Type
- 4.1 Aminocaproic Acid Injection Type Introduction
- 4.1.1 20ml
- 4.1.2 8ml
- 4.1.3 Other
- 4.2 Global Aminocaproic Acid Injection Sales by Type
- 4.2.1 Global Aminocaproic Acid Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Aminocaproic Acid Injection Sales by Type (2021-2032)
- 4.2.3 Global Aminocaproic Acid Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Aminocaproic Acid Injection Revenue by Type
- 4.3.1 Global Aminocaproic Acid Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Aminocaproic Acid Injection Revenue by Type (2021-2032)
- 4.3.3 Global Aminocaproic Acid Injection Revenue Market Share by Type (2021-2032)
5 Aminocaproic Acid Injection Market by Application
- 5.1 Aminocaproic Acid Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Aminocaproic Acid Injection Sales by Application
- 5.2.1 Global Aminocaproic Acid Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Aminocaproic Acid Injection Sales by Application (2021-2032)
- 5.2.3 Global Aminocaproic Acid Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Aminocaproic Acid Injection Revenue by Application
- 5.3.1 Global Aminocaproic Acid Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Aminocaproic Acid Injection Revenue by Application (2021-2032)
- 5.3.3 Global Aminocaproic Acid Injection Revenue Market Share by Application (2021-2032)
6 Global Aminocaproic Acid Injection Sales by Region
- 6.1 Global Aminocaproic Acid Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Aminocaproic Acid Injection Sales by Region (2021-2032)
- 6.2.1 Global Aminocaproic Acid Injection Sales by Region (2021-2026)
- 6.2.2 Global Aminocaproic Acid Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Aminocaproic Acid Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Aminocaproic Acid Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Aminocaproic Acid Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Aminocaproic Acid Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Aminocaproic Acid Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Aminocaproic Acid Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Aminocaproic Acid Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Aminocaproic Acid Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Aminocaproic Acid Injection Revenue by Region
- 7.1 Global Aminocaproic Acid Injection Revenue by Region
- 7.1.1 Global Aminocaproic Acid Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Aminocaproic Acid Injection Revenue by Region (2021-2026)
- 7.1.3 Global Aminocaproic Acid Injection Revenue by Region (2027-2032)
- 7.1.4 Global Aminocaproic Acid Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Aminocaproic Acid Injection Revenue (2021-2032)
- 7.2.2 North America Aminocaproic Acid Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Aminocaproic Acid Injection Revenue (2021-2032)
- 7.3.2 Europe Aminocaproic Acid Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Aminocaproic Acid Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Aminocaproic Acid Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Aminocaproic Acid Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Aminocaproic Acid Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Civica
- 8.1.1 Civica Company Information
- 8.1.2 Civica Business Overview
- 8.1.3 Civica Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Civica Aminocaproic Acid Injection Product Portfolio
- 8.1.5 Civica Recent Developments
- 8.2 Baiao Pharmaceutical
- 8.2.1 Baiao Pharmaceutical Company Information
- 8.2.2 Baiao Pharmaceutical Business Overview
- 8.2.3 Baiao Pharmaceutical Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Baiao Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 8.2.5 Baiao Pharmaceutical Recent Developments
- 8.3 Changzhou Lanling Pharmaceutical
- 8.3.1 Changzhou Lanling Pharmaceutical Company Information
- 8.3.2 Changzhou Lanling Pharmaceutical Business Overview
- 8.3.3 Changzhou Lanling Pharmaceutical Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Changzhou Lanling Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 8.3.5 Changzhou Lanling Pharmaceutical Recent Developments
- 8.4 Chengdu Brilliant Pharmaceutical
- 8.4.1 Chengdu Brilliant Pharmaceutical Company Information
- 8.4.2 Chengdu Brilliant Pharmaceutical Business Overview
- 8.4.3 Chengdu Brilliant Pharmaceutical Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Chengdu Brilliant Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 8.4.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 8.5 Daiichi Sankyo
- 8.5.1 Daiichi Sankyo Company Information
- 8.5.2 Daiichi Sankyo Business Overview
- 8.5.3 Daiichi Sankyo Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Daiichi Sankyo Aminocaproic Acid Injection Product Portfolio
- 8.5.5 Daiichi Sankyo Recent Developments
- 8.6 Guangdong Wonterfull ITD Pharmaceutical
- 8.6.1 Guangdong Wonterfull ITD Pharmaceutical Company Information
- 8.6.2 Guangdong Wonterfull ITD Pharmaceutical Business Overview
- 8.6.3 Guangdong Wonterfull ITD Pharmaceutical Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Guangdong Wonterfull ITD Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 8.6.5 Guangdong Wonterfull ITD Pharmaceutical Recent Developments
- 8.7 Hunan Er-Kang Pharmaceutical
- 8.7.1 Hunan Er-Kang Pharmaceutical Company Information
- 8.7.2 Hunan Er-Kang Pharmaceutical Business Overview
- 8.7.3 Hunan Er-Kang Pharmaceutical Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hunan Er-Kang Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 8.7.5 Hunan Er-Kang Pharmaceutical Recent Developments
- 8.8 Pfizer
- 8.8.1 Pfizer Company Information
- 8.8.2 Pfizer Business Overview
- 8.8.3 Pfizer Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pfizer Aminocaproic Acid Injection Product Portfolio
- 8.8.5 Pfizer Recent Developments
- 8.9 Jiangsu Yuexing Pharmaceutical
- 8.9.1 Jiangsu Yuexing Pharmaceutical Company Information
- 8.9.2 Jiangsu Yuexing Pharmaceutical Business Overview
- 8.9.3 Jiangsu Yuexing Pharmaceutical Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jiangsu Yuexing Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 8.9.5 Jiangsu Yuexing Pharmaceutical Recent Developments
- 8.10 Southwest Pharmaceutical
- 8.10.1 Southwest Pharmaceutical Company Information
- 8.10.2 Southwest Pharmaceutical Business Overview
- 8.10.3 Southwest Pharmaceutical Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Southwest Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 8.10.5 Southwest Pharmaceutical Recent Developments
- 8.11 Yangzhou Zhongbao Pharmaceutical
- 8.11.1 Yangzhou Zhongbao Pharmaceutical Company Information
- 8.11.2 Yangzhou Zhongbao Pharmaceutical Business Overview
- 8.11.3 Yangzhou Zhongbao Pharmaceutical Aminocaproic Acid Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Yangzhou Zhongbao Pharmaceutical Aminocaproic Acid Injection Product Portfolio
- 8.11.5 Yangzhou Zhongbao Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Aminocaproic Acid Injection Value Chain Analysis
- 9.1.1 Aminocaproic Acid Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Aminocaproic Acid Injection Production Mode & Process
- 9.2 Aminocaproic Acid Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Aminocaproic Acid Injection Distributors
- 9.2.3 Aminocaproic Acid Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst